Pharmacology
850 articles · 39 journals
Journals in this subcategory (39)
- Biomedicine & Pharmacotherapy · Elsevier (92)
- Progress in Neuro-Psychopharmacology & Biological Psychiatry · Elsevier (92)
- Drug and Alcohol Dependence · Elsevier (89)
- Fitoterapia · Elsevier (89)
- Neuropsychopharmacology · Elsevier (76)
- Neurotherapeutics · Elsevier (61)
- Steroids · Elsevier (46)
- The Journal of Pharmacology and Experimental Therapeutics · Elsevier (45)
- Drug Resistance Updates · Elsevier (43)
- Intelligent Pharmacy · Elsevier (36)
- Drug Metabolism and Disposition · Elsevier (34)
- Current Radiopharmaceuticals · Elsevier (31)
- Pharmacological Reviews · Elsevier (27)
- European Neuropsychopharmacology · Elsevier (26)
- Prostaglandins & Other Lipid Mediators · Elsevier (16)
- Molecular Pharmacology · Elsevier (14)
- Medicine in Drug Discovery · Elsevier (11)
- Acta Pharmacologica Sinica · Springer Nature (9)
- Nature Reviews Drug Discovery · Springer Nature (8)
- Neuropsychopharmacology · Springer Nature (5)
- Apoptosis · Springer Nature (0)
- BMC Pharmacology and Toxicology · Springer Nature (0)
- BioDrugs · Springer Nature (0)
- Cardiovascular Drugs and Therapy · Springer Nature (0)
- Current Cardiovascular Risk Reports · Springer Nature (0)
- Current Pharmacology Reports · Springer Nature (0)
- DARU Journal of Pharmaceutical Sciences · Springer Nature (0)
- Drug Safety · Springer Nature (0)
- European Journal of Clinical Pharmacology · Springer Nature (0)
- European Journal of Drug Metabolism and Pharmacokinetics · Springer Nature (0)
- Future Journal of Pharmaceutical Sciences · Springer Nature (0)
- Inflammation Research · Springer Nature (0)
- Journal of Pharmacokinetics and Pharmacodynamics · Springer Nature (0)
- Naunyn-Schmiedeberg's Archives of Pharmacology · Springer Nature (0)
- Pharmaceutical Research · Springer Nature (0)
- PharmacoEconomics - Open · Springer Nature (0)
- Pharmacological Reports · Springer Nature (0)
- Psychopharmacology · Springer Nature (0)
- Saudi Pharmaceutical Journal · Springer Nature (0)
-
Montelukast repurposed as a USP2 inhibitor induces c-Myc degradation and suppresses diffuse large B-cell lymphoma
Acta Pharmacologica Sinica, Published online: 19 November 2026; doi:10.1038/s41401-026-01973-9 Montelukast repurposed as a USP2 inhibitor induces c-Myc degradation and suppresses diffuse large B-cell lymphoma
-
Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
-
IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
-
Immunogenicity risk assessment of novel modalities using new approach methodologies
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/s41573-026-01562-9 Novel therapeutic modalities such as cell therapies and gene editors could potentially treat many diseases, but their clinical progression...
-
From hope to adoption: an industry perspective on the maturation of new approach methodologies
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/s41573-026-01583-4 From hope to adoption: an industry perspective on the maturation of new approach methodologies
-
Cancer vaccine development gets complicated
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...
-
How can gene therapy platforms be scaled up to treat thousands of rare diseases?
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
-
Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors
Acta Pharmacologica Sinica, Published online: 13 November 2026; doi:10.1038/s41401-026-01957-9 Structure-based virtual screening with AlphaFold identifies CLIP1-LTK inhibitors
-
The expansion of kinase drug discovery: new targets, platforms and indications
Nature Reviews Drug Discovery, Published online: 11 November 2026; doi:10.1038/s41573-026-01551-y Over the past 25 years, kinase drug discovery has been one of the most active areas in pharmaceutical research and development. This...
-
First factor XIa inhibitor nabs FDA approval for stroke prevention
Nature Reviews Drug Discovery, Published online: 11 November 2026; doi:10.1038/d41573-026-00180-9 First factor XIa inhibitor nabs FDA approval for stroke prevention
-
Gut microbiota-CRAMP axis controls salivary gland immune homeostasis in Sjögren’s disease
Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01945-z Gut microbiota-CRAMP axis controls salivary gland immune homeostasis in Sjögren’s disease
-
A natural small molecule Hdj-15 coordinates the ER and lysosomes to induce ferroptosis by targeting TrxR1
Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01938-y A natural small molecule Hdj-15 coordinates the ER and lysosomes to induce ferroptosis by targeting TrxR1
-
Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target
Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01954-y Mitochondrial antiviral signalling protein (MAVS) in cardiovascular diseases (CVD): a novel pharmacological target
-
Hesperetin ameliorates APAP-induced liver injury by activating a PKC–TFEB axis
Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01956-w Hesperetin ameliorates APAP-induced liver injury by activating a PKC–TFEB axis
-
Bufalin alleviates myocardial ischemia/reperfusion injury by restoring autophagic flux via the RNF216/Beclin-1 axis
Acta Pharmacologica Sinica, Published online: 10 November 2026; doi:10.1038/s41401-026-01962-y Bufalin alleviates myocardial ischemia/reperfusion injury by restoring autophagic flux via the RNF216/Beclin-1 axis
-
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
Nature Reviews Drug Discovery, Published online: 09 November 2026; doi:10.1038/s41573-026-01552-x Conditional biologics (CBs) — protein therapeutics engineered to selectively activate within the tumour microenvironment — have the...
-
Histone lysine demethylases in the third decade: biology and therapeutic prospects
Nature Reviews Drug Discovery, Published online: 09 November 2026; doi:10.1038/s41573-026-01561-w Histone lysine demethylases regulate gene expression and chromatin structure and help to integrate epigenetics with metabolic and immune...
-
Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial
Neuropsychopharmacology, Published online: 29 October 2026; doi:10.1038/s41386-026-02571-3 Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial
-
Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development
Neuropsychopharmacology, Published online: 15 October 2026; doi:10.1038/s41386-026-02574-0 Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development
-
Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study
Neuropsychopharmacology, Published online: 12 October 2026; doi:10.1038/s41386-026-02572-2 Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with...
-
Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
Neuropsychopharmacology, Published online: 12 October 2026; doi:10.1038/s41386-026-02569-x Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
-
A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
Neuropsychopharmacology, Published online: 11 October 2026; doi:10.1038/s41386-026-02575-z A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
- Editorial Board
- Betaine attenuates methamphetamine-induced reinstatement through CAMKK2–AMPK signaling in the nucleus accumbens core
- Associations of peripheral inflammation with hippocampal atrophy in Alzheimer's disease
- Oleic Acid Modulates Prostanoid Levels and Reduces Nitric Oxide Production in Cultured Endothelial Cells
- Multilevel brain functional heterogeneity in major depressive disorder based on normative modeling of multicenter resting-state EEG
- Systematic characterization of subchronic MK-801 administration across mouse strains identifies conserved synaptic alterations and a clear cognitive phenotype in C57BL/6J mice
- MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats
- A ketogenic diet reduces hepatic alcohol metabolism and alcohol consumption in rats